Zinger Key Points
- WeRide stock soared 97.62% following NVIDIA's disclosure of a significant share acquisition.
- SpringWorks Therapeutics surged 42.58% on news of potential acquisition talks with Merck KGaA.
- Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds profits in volatile markets. Claim your 7-day free trial now.
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?
- WeRide Inc. WRD shares rocketed 97.62% after NVIDIA Corporation NVDA disclosed a stake of 1.74 million shares in a 13F filing.
- GDS Holdings Limited GDS stock escalated 43.45%, probably after President Trump had reportedly postponed tariffs on packages under $800 from China. Additionally, optimism towards China’s DeepSeek AI model has also lifted stocks recently.
- SpringWorks Therapeutics, Inc. SWTX shares jumped 42.58% after announcing Merck KGaA MKGAF MKKGY is in advanced discussions to acquire the company.
- Recursion Pharmaceuticals, Inc. RXRX shares increased 40.59%.
- Sable Offshore Corp. SOC stock upped 39.09%.
- GeneDx Holdings Corp. WGS shares rose 28.23% after the company announced UltraRapid Whole Genome Sequencing, which will deliver actionable results within 48 hours.
- VNET Group, Inc. VNET stock upped 28.22%, probably amid a possible rebound after falling last week due to AI competition concerns related to China’s DeepSeek AI model.
- Insperity, Inc. NSP stock increased 25.99% after the company reported better-than-expected fourth-quarter results.
- CRISPR Therapeutics AG CRSP stock grew 25.21% after the company reported better-than-expected fourth-quarter financial results. Several analysts raised the price forecast on the stock.
- Axsome Therapeutics, Inc. AXSM stock grew 24.01% after the company reached a settlement agreement with Teva Pharmaceutical TEVA, resolving all patent litigation related to its Auvelity product. Several analysts raised the price forecast on the stock.
Photo via WeRide
Loading...
Loading...
CRSPCRISPR Therapeutics AG
$38.261.40%
Edge Rankings
Momentum
21.36
Growth
-
Quality
-
Value
5.35
Price Trend
Short
Medium
Long
WGSGeneDx Holdings Corp
$66.516.72%
WRDWeRide Inc
$7.4212.8%
AXSMAxsome Therapeutics Inc
$112.21-0.03%
GDSGDS Holdings Ltd
$28.279.74%
MKGAFMerck KGaA
$140.50-2.36%
MKKGYMerck KGaA
--%
NSPInsperity Inc
$66.881.30%
NVDANVIDIA Corp
$114.222.34%
RXRXRecursion Pharmaceuticals Inc
$5.764.73%
SOCSable Offshore Corp
$20.271.30%
SWTXSpringWorks Therapeutics Inc
$46.250.09%
TEVATeva Pharmaceutical Industries Ltd
$16.193.66%
VNETVNET Group Inc
$7.1013.2%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in